Issue 28, 2010

Novel Fe3O4@YPO4 : Re (Re = Tb, Eu) multifunctional magnetic–fluorescent hybrid spheres for biomedical applications

Abstract

Novel Fe3O4@YPO4 : Re (Re = Tb, Eu) magnetic–fluorescent hybrid spheres are prepared and present a sustained release behavior for the anticancer drug doxorubicin (DOX) and successful labeling of human cervical carcinoma Hela cells, suggesting promising potential as multifunctional biosensors for biomedical applications.

Graphical abstract: Novel Fe3O4@YPO4 : Re (Re = Tb, Eu) multifunctional magnetic–fluorescent hybrid spheres for biomedical applications

Supplementary files

Article information

Article type
Communication
Submitted
07 Mar 2010
Accepted
24 May 2010
First published
15 Jun 2010

Chem. Commun., 2010,46, 5100-5102

Novel Fe3O4@YPO4 : Re (Re = Tb, Eu) multifunctional magnetic–fluorescent hybrid spheres for biomedical applications

W. Wang, M. Zou and K. Chen, Chem. Commun., 2010, 46, 5100 DOI: 10.1039/C0CC00262C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements